HEALTHCARE & MEDICAL INVESTMENT CORPORATION

(3455)
  Report
Delayed Japan Exchange  -  05/20 02:00:00 am EDT
163300.00 JPY   +0.68%
01/17Healthcare & Medical Investment Corporation has filed an IPO.
CI
01/17Healthcare & Medical Investment Corporation agreed to acquire Ten properties in Japan for ¥11.4 billion.
CI
2021Healthcare & Medical Investment Corporation Reports Earnings Results for the Half Year Ended July 31, 2021
CI
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Healthcare & Medical Investment Corporation agreed to acquire SOMPO Care Raviere Hamakawasaki, Hanakotoba Shinyokohama, Hanakotoba Shinyokohama Building No. 2, Hanakotoba Odawara, Verde Minowa, Verde Hotaka, Sunny Life Kitashinagawa and Ship Senri Building from Sumitomo Mitsui Finance and Leasing Company, Limited, Yoei Co.,Ltd. MYGK 1 LLC and MYGK 2 LLC for ¥22.7 billion.

01/11/2019 EDT

Healthcare & Medical Investment Corporation (TSE:3455) agreed to acquire SOMPO Care Raviere Hamakawasaki, Hanakotoba Shinyokohama, Hanakotoba Shinyokohama Building No. 2, Hanakotoba Odawara, Verde Minowa, Verde Hotaka, Sunny Life Kitashinagawa and Ship Senri Building from Sumitomo Mitsui Finance and Leasing Company, Limited, Yoei Co.,Ltd. MYGK 1 LLC and MYGK 2 LLC for ¥22.7 billion on January 9, 2019. As on January 11, 2019, the sales contract was concluded. The consideration will be made as full payment at delivery. MYGK 2 LLC agreed to sell SOMPO Care Raviere Hamakawasaki for ¥1.7 billion, Hanakotoba Shinyokohama Building 2 for 375 million, MYGK 1 LLC agreed to sell Hanakotoba Shinyokohama for 2.1 billion, Hanakotoba Odawara for 880 million, Sumitomo Mitsui Finance and Leasing Company, Limited agreed to sell Verde Minowa for 1.6 billion, Verde Hotaka for 1.3 billion, Ship Senri Building for 12.9 billion and Yoei Co., Ltd. agreed to sell Sunnylife Kitashinagawa for 1.8 billion. The deal will be funded with proceeds from issuance of new investment units (public offering) resolved at Healthcare & Medical Investment Corporation's Board of Directors held on January 11, 2019, borrowings and funds in hand. The deal was deliberated and approved by the Compliance Committee on January 9, 2019 and deliberations and approval by the Management Committee on January 11, 2019. The scheduled acquisition date is February 1, 2019.


© S&P Capital IQ 2019
All news about HEALTHCARE & MEDICAL INVESTMENT CORPORATION
01/17Healthcare & Medical Investment Corporation has filed an IPO.
CI
01/17Healthcare & Medical Investment Corporation agreed to acquire Ten properties in Japan f..
CI
2021Healthcare & Medical Investment Corporation Reports Earnings Results for the Half Year ..
CI
2021Healthcare & Medical Investment Corporation agreed to acquire Nichii Home Nishikokubunj..
CI
2020Healthcare & Medical Investment Corporation completed the acquisition of Sunny Life Kam..
CI
2020Healthcare & Medical Investment Corporation signed a contract to acquire Sunny Life Kam..
CI
2019Healthcare & Medical Investment Corporation completed the acquisition of SOMPO Care Rav..
CI
2019Healthcare & Medical Investment Corporation agreed to acquire SOMPO Care Raviere Hamaka..
CI
2018Healthcare & Medical Investment Corporation completed the acquisition of trust benefici..
CI
2018Healthcare & Medical Investment Corporation signed a contract to acquire trust benefici..
CI
More news
Financials
Sales 2021 4 116 M 32,2 M 32,2 M
Net income 2021 1 820 M 14,2 M 14,2 M
Net Debt 2021 31 358 M 245 M 245 M
P/E ratio 2021 26,1x
Yield 2021 -
Capitalization 58 706 M 459 M 459 M
EV / Sales 2020 16,7x
EV / Sales 2021 19,2x
Nbr of Employees -
Free-Float 94,6%
Chart HEALTHCARE & MEDICAL INVESTMENT CORPORATION
Duration : Period :
Healthcare & Medical Investment Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HEALTHCARE & MEDICAL INVESTMENT CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 163 300,00
Average target price
Spread / Average Target -
Managers and Directors
Masayuki Tamura Investor Relations Contact
Seiji Yoshioka Executive Officer
Yasuo Shida Supervisory Officer
Yukihiko Fujimoto Supervisory Officer
Sector and Competitors